COO
COOPER COMPANIES, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$55.29
+2.82%Sep 18, 2026, 11:37 UTC
Activist investor Jana Partners called on Cooper Cos. to search for a new CEO.
Source:Sep 17, 2026, 23:02 UTC
Activist hedge fund Jana Partners demanded that contact lens maker CooperVision replace its CEO and evaluate a sale of its core business.
Source:Sep 12, 2026, 18:49 UTC
Shares of The Cooper Companies fell $9.31 (-14.6%) on September 10, 2026, after the company reported Q3 2026 results that included U.S. channel inventory destocking and other negative surprises.
Sep 11, 2026, 01:53 UTC
CooperCompanies reported Q2 CY2026 revenue of $1.07 billion, flat year on year and below analyst estimates, with adjusted EPS of $1.15 beating consensus.
Source:Sep 10, 2026, 16:11 UTC
Cooper Cos. wrapped up a strategic review without plans to seek a deal.
Source:Sep 10, 2026, 13:45 UTC
Cooper Companies guided Q4 (August-October) adjusted EPS to $1.05-$1.09 and revenue to $1.06-$1.08 billion, below analyst estimates of $1.19 and $1.11 billion respectively.
Source:Sep 10, 2026, 11:52 UTC
Cooper Companies Inc cut its FY26 guidance below estimates.
Sep 9, 2026, 20:38 UTC
Cooper Companies reported Q3 2026 revenue of $1,066.2 million, GAAP net income of $432.8 million, and GAAP diluted EPS of $2.24, and issued FY2026 non-GAAP diluted EPS guidance of $4.51-$4.55.
Sep 1, 2026, 11:08 UTC
Cooper launched an AI-native hiring platform that automates candidate sourcing, screening, interviewing, and applicant tracking.
Source:Jun 26, 2026, 17:50 UTC
Cooper Companies is advancing discussions to sell its surgical business unit CooperSurgical, with multiple interested parties.
Source:Jun 5, 2026, 00:00 UTC
Rocket Lab Corp appointed Agostino Ricupati as Vice President, Corporate Controller and Chief Accounting Officer, effective June 3, 2026.
Jun 4, 2026, 22:45 UTC
The Cooper Companies reported Q2 earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.1 per share.
Source: